Similar articles

• [To discuss the vancomycin-resistant staphylococcus aureus and vancomycin-resistant enterococcus from laboratory view].

  Chen MJ, Xu YC. Chen MJ, et al. Zhonghua Yi Xue Za Zhi. 2006 Apr 18;86(15):1009-10. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16784699 Chinese. No abstract available.
• Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.

  Glew RH, Pavuk RA, Shuster A, Alfred HJ. Glew RH, et al. Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7152738
• Vancomycin peak serum concentration monitoring.

  Tam VH, Moore GE, Triller DM, Briceland LL. Tam VH, et al. J Intraven Nurs. 1999 Nov-Dec;22(6):336-42. J Intraven Nurs. 1999. PMID: 10865602 Review.
• Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.

  Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I. Chaftari AM, et al. Int J Antimicrob Agents. 2010 Aug;36(2):182-6. doi: 10.1016/j.ijantimicag.2010.03.015. Epub 2010 May 8. Int J Antimicrob Agents. 2010. PMID: 20452752
• Serum vancomycin concentrations: reappraisal of their clinical value.

  Cantú TG, Yamanaka-Yuen NA, Lietman PS. Cantú TG, et al. Clin Infect Dis. 1994 Apr;18(4):533-43. Clin Infect Dis. 1994. PMID: 8038306 Review.